Calcium Hydroxyapatite Fillers

ABSTRACT

Calcium hydroxyapatite fillers have unique advantages over other fillers in regards to duration of action and volume of product required for augmentation, especially in the midface and lower face. In this article, we describe our experience with calcium hydroxyapatite fillers and compare them with other available filler products.

KEYWORDS

Soft tissue fillers - calcium hydroxyapatite - facial augmentation

REFERENCES

• 1 Hubbard W. Bioform Implants: Biocompatibility. Franksville, WI: Bioform, Inc.; 2003
• 2 Marmur E S, Phelps R, Goldberg D J. Clinical, histologic and electron microscopic findings after injection of a calcium hydroxylapatite filler.  J Cosmet Laser Ther. 2004;  6 223-226
• 3 Berlin A L, Hussain M, Goldberg D J. Calcium hydroxylapatite filler for facial renation: a histologic and immunohistochemical analysis.  Dermatol Surg. 2008;  34 (Suppl 1) S64-S67
• 4 Drobeck H P, Rothstein S S, Gumaer K I, Sherer A D, Slighter R G. Histologic observation of soft tissue responses to implanted, multifaceted particles and discs of hydroxylapatite.  J Oral Maxillofac Surg. 1984;  42 143-149
• 5 Lemperle G, Morhenn V, Charrier U. Human histology and persistence of various injectable filler substances for soft tissue augmentation.  Aesthetic Plast Surg. 2003;  27 354-366 discussion 367
• 6 Holzapfel A M, Mangat D S, Barron D S. Soft-tissue augmentation with calcium hydroxylapatite: histological analysis.  Arch Facial Plast Surg. 2008;  10 335-338
• 7 Hubbard W. Bioform Implants: Durability. Franksville, WI: Bioform, Inc.; 2002
• 8 Mayer R, Lightfoot M, Jung I. Preliminary evaluation of calcium hydroxylapatite as a transurethral bulking agent for stress urinary incontinence.  Urology. 2001;  57 434-438
• 9 Hubbard W. Bioform Implants: Evaluation of Migration Potential. Franksville, WI: Bioform, Inc.; 2003
• 10 Felderman L I. Radiesse for facial rejuvenation.  Cosmet Dermatol. 2005;  18 823-826
• 11 Busso M, Karlsberg P L. Cheek augmentation and rejuvenation using injectable calcium hydroxylapatite (Radiesse).  Cosmet Dermatol. 2006;  19 583-588
• 12 Tzikas T L. Evaluation of the Radiance FN soft tissue filler for facial soft tissue augmentation.  Arch Facial Plast Surg. 2004;  6 234-239
• 13 Stupak H D, Moulthrop T HM, Wheatley P, Tauman A V, Johnson Jr C M. Calcium hydroxylapatite gel (Radiesse) injection for the correction of postrhinoplasty contour deficiencies and asymmetries.  Arch Facial Plast Surg. 2007;  9 130-136
• 14 Busso M, Voigts R. An investigation of changes in physical properties of injectable calcium hydroxylapatite in a carrier gel when mixed with lidocaine and with lidocaine/epinephrine.  Dermatol Surg. 2008;  34 (Suppl 1) S16-S23 discussion S24
• 15 Marmur E, Green L, Busso M. Controlled, randomized study of pain levels in subjects treated with calcium hydroxylapatite premixed with lidocaine for correction of nasolabial folds.  Dermatol Surg. 2010;  36 309-315
• 16 Graivier M H, Bass L S, Busso M et al.. Calcium hydroxylapatite (Radiesse) for correction of the mid- and lower face: consensus recommendations.  Plast Reconstr Surg. 2007;  120 (Suppl) 55-66S
• 17 Tzikas T L. A 52-month summary of results using calcium hydroxylapatite for facial soft tissue augmentation.  Dermatol Surg. 2008;  34 (Suppl 1) S9-S15
• 18 Moers-Carpi M M, Tufet J O. Calcium hydroxylapatite versus nonanimal stabilized hyaluronic acid for the correction of nasolabial folds: a 12-month, multicenter, prospective, randomized, controlled, split-face trial.  Dermatol Surg. 2008;  34 210-215
• 19 Moers-Carpi M M, Vogt S, Santos B M, Planas J, Vallve S R, Howell D J. A multicenter, randomized trial comparing calcium hydroxylapatite to two hyaluronic acids for treatment of nasolabial folds.  Dermatol Surg. 2007;  33 (Suppl 2) S144-S151